Friday’s analyst upgrades and downgrades

Desjardins raised BRP’s price target to C$138 from C$130 and reiterated a buy after a fiscal Q4 beat; shares are ~17% below 52-week highs and trade at 6.2x Poirier’s 2027 EV/EBITDA (an 18% discount to Polaris). Poirier forecasts free cash flow of C$805m (2027), C$819m (2028) and C$892m (2029) and expects leverage to fall from 1.9x (FY26) to ~0.1x by FY29, while introducing FY29 estimates of C$9.9bn revenue, 15.4% EBITDA margin and C$10.05 normalized EPS. National Bank upgraded Tidewater to sector perform and doubled its PT to C$9.50 despite Q4 EBITDA of $2m vs $15.5m consensus, citing 2026 adjusted EBITDA guidance of C$150–170m and potential asset sales/restarts. Canaccord initiated speculative-buy coverage on NOVAGOLD (US$13 PT) highlighting the 46 Moz Donlin asset and on Canopy Growth (C$2 PT) noting a strategic pivot toward in‑house supply and margin improvement.

Analysis

BRP (powersports OEM) has a levered optionality story that goes beyond a single quarter: a structurally stronger FCF profile combined with targeted product refreshes materially reshapes capital allocation. Expect the marginal dollar of FCF over the next 24–36 months to flow toward either buybacks or targeted M&A in adjacent outdoor-vehicle niches (accessories, lightweight electrified drivetrains), which would amplify upside more than a simple multiple expansion. Suppliers of high-torque small-displacement engines, electronic control units and specialty drivetrain components are second-order beneficiaries — increased unit mix toward premium/high-margin models will raise per-unit parts content and spare-parts revenue for 12–36 months after ramp.

Key risks are classic cyclicality and execution on new platforms: a 12–24 month consumer pullback or a delayed homologation/quality issue on a flagship model would compress margins quickly via warranty and channel inventory adjustments. Watch rolling inventory at dealer networks and quarterly FCF conversion as early warning indicators; a single missed FCF quarter will reprice leverage assumptions and push management to defer buybacks. For resource/development stories (large gold project) the main near-term variable is non-dilutive financing optionality — strategic offtake, streaming or export-credit agency support can convert a long-dated permit into a financed asset, while failure forces equity dilution and pushes option value toward zero.

Relative-value trades should focus on asymmetric payoffs: express conviction with capped-loss structures (call spreads, buy-writes) rather than outright leverage. For midstream/refining-linked names with short-term operational catalysts (crack spread tails, restarts), liquidity windows around asset-sale announcements are the likeliest alpha pulses in the next 3–9 months. For the cannabis pivot, margin improvement from vertical integration is real but execution-dependent; calibrate size to runway for SKU rationalization (3–9 months) and avoid being directionally exposed through peak inventory resets.

Contrarian: the market is likely under-pricing the near-certainty of leverage reduction in high-FCF cyclicals but over-pricing optionality in remote, high-capex resource projects; lean into the former with structured equity and hedge the latter via time-limited, low-cost optionality.

Key Decisions for Investors

• Long DOOO via a 9–12 month 20–30% OTM call spread sized 2–3% portfolio exposure (max loss = premium). Rationale: asymmetric upside from re-rating or buyback/M&A action; risk controlled if a cyclical slowdown compresses multiples.
• Pair trade: long DOOO / short PII (Polar competitor) sized to dollar-neutral, horizon 6–18 months. Trade targets convergence in EV/EBITDA spread driven by BRP’s stronger FCF conversion; stop-loss if relative spread widens beyond 25% vs entry.
• TWM.TO tactical long: buy the equity into guidance-driven rerate and hedge with a 6–9 month put at ~10% OTM to protect against operational setbacks during pipeline restarts. Position size 1–2% portfolio.
• NG (high-capex gold project): express speculative upside with small, long-dated call options or LEAPS rather than equity to limit dilution risk; cap exposure to <1% portfolio and size up only if a non-dilutive financing announcement occurs.
• CGC (cannabis pivot): buy a moderate equity stake and sell 6–12 month covered calls to monetize position while management executes SKU rationalization; trim on sustained improvement in gross margin over two consecutive quarters.